RAB4A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.513400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.520400E-01
Normal-vs-Stage2
6.903000E-01
Normal-vs-Stage3
6.599800E-01
Normal-vs-Stage4
2.869000E-01
Stage1-vs-Stage2
3.350200E-02
Stage1-vs-Stage3
9.817800E-02
Stage1-vs-Stage4
8.019200E-01
Stage2-vs-Stage3
1.729230E-01
Stage2-vs-Stage4
2.746500E-02
Stage3-vs-Stage4
1.379440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.026000E-01
Normal-vs-AfricanAmerican
2.396400E-01
Normal-vs-Asian
7.246600E-01
Caucasian-vs-AfricanAmerican
3.540000E-02
Caucasian-vs-Asian
8.900400E-01
AfricanAmerican-vs-Asian
6.220100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.822200E-01
Normal-vs-Female
7.666000E-01
Male-vs-Female
2.515400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.110200E-01
Normal-vs-Age(41-60Yrs)
5.351600E-01
Normal-vs-Age(61-80Yrs)
7.520600E-01
Normal-vs-Age(81-100Yrs)
4.898800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.796000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.890600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.404200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.012800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.665200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.374400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.263800E-01
Normal-vs-Daily Drinker
7.287400E-01
Normal-vs-Weekly Drinker
8.018200E-01
Normal-vs-Occasional Drinker
2.749200E-01
Normal-vs-Social Drinker
8.534400E-01
Non Drinker-vs-Daily Drinker
1.352780E-01
Non Drinker-vs-Weekly Drinker
9.490800E-01
Non Drinker-vs-Occasional Drinker
1.724990E-01
Non Drinker-vs-Social Drinker
5.773400E-01
Daily Drinker-vs-Weekly Drinker
2.760200E-01
Daily Drinker-vs-Occasional Drinker
6.539700E-03
Daily Drinker-vs-Social Drinker
3.066800E-01
Weekly Drinker-vs-Occasional Drinker
2.610400E-01
Weekly Drinker-vs-Social Drinker
7.548000E-01
Occasional Drinker-vs-Social Drinker
5.087900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.185600E-02
Normal-vs-Grade 2
2.937200E-03
Normal-vs-Grade 3
3.179200E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.722200E-01
Grade 1-vs-Grade 3
9.625800E-01
Grade 1-vs-Grade 4
4.185600E-02
Grade 2-vs-Grade 3
2.661800E-01
Grade 2-vs-Grade 4
2.937200E-03
Grade 3-vs-Grade 4
3.179200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.659800E-01
Normal-vs-NonDiabetic
6.244200E-01
Diabetic-vs-NonDiabetic
9.626500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.660400E-01
Normal-vs-NoPancreatitis
6.910600E-01
Pancreatitis-vs-NoPancreatitis
3.901600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.126200E-01
Normal-vs-N1
7.141600E-01
N0-vs-N1
1.522410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.883400E-01
Normal-vs-TP53-NonMutant
3.488400E-01
TP53-Mutant-vs-TP53-NonMutant
2.949600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
